Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19Carcinoma, Non-Small-Cell Lung 9Rhabdomyosarcoma 6Triple Negative Breast Neoplasms 5Hodgkin Disease 4Recurrence 3Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2Neoplasm Metastasis 2Lung Neoplasms 2Adenocarcinoma 2Solitary Fibrous Tumor, Pleural 1NSCLC 1Metastatic HER2-positive Breast Cancer 1Mesothelioma, Malignant 1Lung Diseases, Interstitial 1Locally Advanced Non-Small Cell Lung Cancer 1HR+HER2- Breast Cancer 1HER2-negative Metastatic Breast Cancer 1Fludzoparib" and Anti-angiogenic 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Advanced Breast Cancer 1

Interventions

pembrolizumab 1Vinorelbine 1Surveys and Questionnaires 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Observation 1Nivolumab 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Dexamethasone 1Carboplatin 1Bevacizumab 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Vinorelbine × 1 year × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡